ci 988 has been researched along with yf 476 in 1 studies
| Studies (ci 988) | Trials (ci 988) | Recent Studies (post-2010) (ci 988) | Studies (yf 476) | Trials (yf 476) | Recent Studies (post-2010) (yf 476) |
|---|---|---|---|---|---|
| 147 | 8 | 14 | 43 | 9 | 17 |
| Protein | Taxonomy | ci 988 (IC50) | yf 476 (IC50) |
|---|---|---|---|
| Cholecystokinin receptor type A | Rattus norvegicus (Norway rat) | 0.502 | |
| Gastrin/cholecystokinin type B receptor | Rattus norvegicus (Norway rat) | 0.0001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Low, CM; Vinter, JG | 1 |
1 other study(ies) available for ci 988 and yf 476
| Article | Year |
|---|---|
Rationalizing the activities of diverse cholecystokinin 2 receptor antagonists using molecular field points.
Topics: Animals; Benzoates; Binding Sites; Binding, Competitive; Bridged-Ring Compounds; Cyclohexanes; Gastric Mucosa; Guinea Pigs; Heterocyclic Compounds, 2-Ring; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Least-Squares Analysis; Ligands; Linear Models; Models, Molecular; Pancreas; Phthalic Acids; Quantitative Structure-Activity Relationship; Radioligand Assay; Rats; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B | 2008 |